Loading…

Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014

Objectives Hepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known. Methods We anal...

Full description

Saved in:
Bibliographic Details
Published in:Public health reports (1974) 2020-07, Vol.135 (4), p.461-471
Main Authors: Evans, Mary E, Person Marissa, Reilley Brigg, Leston Jessica, Haverkate, Richard, McCollum, Jeffrey T, Apostolou Andria, Bohm, Michele K, Van Handel Michelle, Bixler Danae, Mitsch, Andrew J, Haberling, Dana L, Hatcher, Sarah M, Weiser, Thomas, Elmore, Kim, Teshale, Eyasu H, Weidle, Paul J, Peters, Philip J, Buchacz Kate
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1174-f2032ee6a4cc85f829adf1e9756259ba1929d061606c2309fc0602708adfff003
cites
container_end_page 471
container_issue 4
container_start_page 461
container_title Public health reports (1974)
container_volume 135
creator Evans, Mary E
Person Marissa
Reilley Brigg
Leston Jessica
Haverkate, Richard
McCollum, Jeffrey T
Apostolou Andria
Bohm, Michele K
Van Handel Michelle
Bixler Danae
Mitsch, Andrew J
Haberling, Dana L
Hatcher, Sarah M
Weiser, Thomas
Elmore, Kim
Teshale, Eyasu H
Weidle, Paul J
Peters, Philip J
Buchacz Kate
description Objectives Hepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known. Methods We analyzed 2010-2014 Indian Health Service data on health care encounters to assess regional and temporal trends in IDU indicators among adults aged ≥18 years. IDU indicators included acute or chronic HCV infection (only among adults aged 18-35 years), arm cellulitis and abscess, OUD, and opioid-related overdose. We calculated rates per 10 000 AI/AN adults for each IDU indicator overall and stratified by sex, age group, and region and evaluated rate ratios and trends by using Poisson regression analysis. Results Rates of HCV infection among adults aged 18-35 increased 9.4% per year, and rates of OUD among all adults increased 13.3% per year from 2010 to 2014. The rate of HCV infection among young women was approximately 1.3 times that among young men. Rates of opioid-related overdose among adults aged
doi_str_mv 10.1177/0033354920937284
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2429086434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2429086434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1174-f2032ee6a4cc85f829adf1e9756259ba1929d061606c2309fc0602708adfff003</originalsourceid><addsrcrecordid>eNotT01PwzAMjRBIlMGdYySuFBwnzccRDcYmVeLAdp5CmkCrKYWk5feTAT48y35P79mEXDO4Y0ypewDOeSMMguEKtTghFRNS16iVOiXVka6P_Dm5yHmAUsh4Rdpt8rHLtI90E7ve2WlMmY6hTIN3Uz9G-pjmd7rL_vZXYSNde3uYPuirT9-9K2sEBnUBcUnOgj1kf_XfF2S3etou13X78rxZPrS1K6eKOiBw9F5a4ZxugkZju8C8UY3ExrxZZtB0IJkE6ZCDCQ4koAJdZCGUTxbk5s_3M41fs8_TfhjnFEvkHgUa0FJwwX8A9ahLuw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429086434</pqid></control><display><type>article</type><title>Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014</title><source>JSTOR Archival Journals and Primary Sources Collection【Remote access available】</source><source>PAIS Index</source><source>Sage Journals Online</source><source>PubMed Central</source><creator>Evans, Mary E ; Person Marissa ; Reilley Brigg ; Leston Jessica ; Haverkate, Richard ; McCollum, Jeffrey T ; Apostolou Andria ; Bohm, Michele K ; Van Handel Michelle ; Bixler Danae ; Mitsch, Andrew J ; Haberling, Dana L ; Hatcher, Sarah M ; Weiser, Thomas ; Elmore, Kim ; Teshale, Eyasu H ; Weidle, Paul J ; Peters, Philip J ; Buchacz Kate</creator><creatorcontrib>Evans, Mary E ; Person Marissa ; Reilley Brigg ; Leston Jessica ; Haverkate, Richard ; McCollum, Jeffrey T ; Apostolou Andria ; Bohm, Michele K ; Van Handel Michelle ; Bixler Danae ; Mitsch, Andrew J ; Haberling, Dana L ; Hatcher, Sarah M ; Weiser, Thomas ; Elmore, Kim ; Teshale, Eyasu H ; Weidle, Paul J ; Peters, Philip J ; Buchacz Kate</creatorcontrib><description>Objectives Hepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known. Methods We analyzed 2010-2014 Indian Health Service data on health care encounters to assess regional and temporal trends in IDU indicators among adults aged ≥18 years. IDU indicators included acute or chronic HCV infection (only among adults aged 18-35 years), arm cellulitis and abscess, OUD, and opioid-related overdose. We calculated rates per 10 000 AI/AN adults for each IDU indicator overall and stratified by sex, age group, and region and evaluated rate ratios and trends by using Poisson regression analysis. Results Rates of HCV infection among adults aged 18-35 increased 9.4% per year, and rates of OUD among all adults increased 13.3% per year from 2010 to 2014. The rate of HCV infection among young women was approximately 1.3 times that among young men. Rates of opioid-related overdose among adults aged &lt;50 years were approximately 1.4 times the rates among adults aged ≥50 years. Among young adults with HCV infection, 25.6% had concurrent OUD. Among all adults with arm cellulitis and abscess, 5.6% had concurrent OUD. Conclusions Rates of HCV infection and OUD increased significantly in the AI/AN population. Strengthened public health efforts could ensure that AI/AN communities can address increasing needs for culturally appropriate interventions, including comprehensive syringe services programs, medication-assisted treatment, and opioid-related overdose prevention and can meet the growing need for treatment of HCV infection.</description><identifier>ISSN: 0033-3549</identifier><identifier>EISSN: 1468-2877</identifier><identifier>DOI: 10.1177/0033354920937284</identifier><language>eng</language><publisher>Cary: SAGE PUBLICATIONS, INC</publisher><subject>Abscesses ; Adults ; Cellulitis ; Chronic infection ; Disease transmission ; Drug addiction ; Drug use ; Epidemiology ; Health services ; Hepatitis ; Hepatitis C ; HIV ; Human immunodeficiency virus ; Indicators ; Infections ; Injection ; Men ; Narcotics ; Opioids ; Overdose ; Prevention ; Public health ; Regression analysis ; Sexually transmitted diseases ; STD ; Trends ; Viruses ; Young adults</subject><ispartof>Public health reports (1974), 2020-07, Vol.135 (4), p.461-471</ispartof><rights>2020, Association of Schools and Programs of Public Health</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1174-f2032ee6a4cc85f829adf1e9756259ba1929d061606c2309fc0602708adfff003</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27866,27924,27925</link.rule.ids></links><search><creatorcontrib>Evans, Mary E</creatorcontrib><creatorcontrib>Person Marissa</creatorcontrib><creatorcontrib>Reilley Brigg</creatorcontrib><creatorcontrib>Leston Jessica</creatorcontrib><creatorcontrib>Haverkate, Richard</creatorcontrib><creatorcontrib>McCollum, Jeffrey T</creatorcontrib><creatorcontrib>Apostolou Andria</creatorcontrib><creatorcontrib>Bohm, Michele K</creatorcontrib><creatorcontrib>Van Handel Michelle</creatorcontrib><creatorcontrib>Bixler Danae</creatorcontrib><creatorcontrib>Mitsch, Andrew J</creatorcontrib><creatorcontrib>Haberling, Dana L</creatorcontrib><creatorcontrib>Hatcher, Sarah M</creatorcontrib><creatorcontrib>Weiser, Thomas</creatorcontrib><creatorcontrib>Elmore, Kim</creatorcontrib><creatorcontrib>Teshale, Eyasu H</creatorcontrib><creatorcontrib>Weidle, Paul J</creatorcontrib><creatorcontrib>Peters, Philip J</creatorcontrib><creatorcontrib>Buchacz Kate</creatorcontrib><title>Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014</title><title>Public health reports (1974)</title><description>Objectives Hepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known. Methods We analyzed 2010-2014 Indian Health Service data on health care encounters to assess regional and temporal trends in IDU indicators among adults aged ≥18 years. IDU indicators included acute or chronic HCV infection (only among adults aged 18-35 years), arm cellulitis and abscess, OUD, and opioid-related overdose. We calculated rates per 10 000 AI/AN adults for each IDU indicator overall and stratified by sex, age group, and region and evaluated rate ratios and trends by using Poisson regression analysis. Results Rates of HCV infection among adults aged 18-35 increased 9.4% per year, and rates of OUD among all adults increased 13.3% per year from 2010 to 2014. The rate of HCV infection among young women was approximately 1.3 times that among young men. Rates of opioid-related overdose among adults aged &lt;50 years were approximately 1.4 times the rates among adults aged ≥50 years. Among young adults with HCV infection, 25.6% had concurrent OUD. Among all adults with arm cellulitis and abscess, 5.6% had concurrent OUD. Conclusions Rates of HCV infection and OUD increased significantly in the AI/AN population. Strengthened public health efforts could ensure that AI/AN communities can address increasing needs for culturally appropriate interventions, including comprehensive syringe services programs, medication-assisted treatment, and opioid-related overdose prevention and can meet the growing need for treatment of HCV infection.</description><subject>Abscesses</subject><subject>Adults</subject><subject>Cellulitis</subject><subject>Chronic infection</subject><subject>Disease transmission</subject><subject>Drug addiction</subject><subject>Drug use</subject><subject>Epidemiology</subject><subject>Health services</subject><subject>Hepatitis</subject><subject>Hepatitis C</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Indicators</subject><subject>Infections</subject><subject>Injection</subject><subject>Men</subject><subject>Narcotics</subject><subject>Opioids</subject><subject>Overdose</subject><subject>Prevention</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Trends</subject><subject>Viruses</subject><subject>Young adults</subject><issn>0033-3549</issn><issn>1468-2877</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><recordid>eNotT01PwzAMjRBIlMGdYySuFBwnzccRDcYmVeLAdp5CmkCrKYWk5feTAT48y35P79mEXDO4Y0ypewDOeSMMguEKtTghFRNS16iVOiXVka6P_Dm5yHmAUsh4Rdpt8rHLtI90E7ve2WlMmY6hTIN3Uz9G-pjmd7rL_vZXYSNde3uYPuirT9-9K2sEBnUBcUnOgj1kf_XfF2S3etou13X78rxZPrS1K6eKOiBw9F5a4ZxugkZju8C8UY3ExrxZZtB0IJkE6ZCDCQ4koAJdZCGUTxbk5s_3M41fs8_TfhjnFEvkHgUa0FJwwX8A9ahLuw</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Evans, Mary E</creator><creator>Person Marissa</creator><creator>Reilley Brigg</creator><creator>Leston Jessica</creator><creator>Haverkate, Richard</creator><creator>McCollum, Jeffrey T</creator><creator>Apostolou Andria</creator><creator>Bohm, Michele K</creator><creator>Van Handel Michelle</creator><creator>Bixler Danae</creator><creator>Mitsch, Andrew J</creator><creator>Haberling, Dana L</creator><creator>Hatcher, Sarah M</creator><creator>Weiser, Thomas</creator><creator>Elmore, Kim</creator><creator>Teshale, Eyasu H</creator><creator>Weidle, Paul J</creator><creator>Peters, Philip J</creator><creator>Buchacz Kate</creator><general>SAGE PUBLICATIONS, INC</general><scope>7TQ</scope><scope>ASE</scope><scope>DHY</scope><scope>DON</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20200701</creationdate><title>Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014</title><author>Evans, Mary E ; Person Marissa ; Reilley Brigg ; Leston Jessica ; Haverkate, Richard ; McCollum, Jeffrey T ; Apostolou Andria ; Bohm, Michele K ; Van Handel Michelle ; Bixler Danae ; Mitsch, Andrew J ; Haberling, Dana L ; Hatcher, Sarah M ; Weiser, Thomas ; Elmore, Kim ; Teshale, Eyasu H ; Weidle, Paul J ; Peters, Philip J ; Buchacz Kate</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1174-f2032ee6a4cc85f829adf1e9756259ba1929d061606c2309fc0602708adfff003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Abscesses</topic><topic>Adults</topic><topic>Cellulitis</topic><topic>Chronic infection</topic><topic>Disease transmission</topic><topic>Drug addiction</topic><topic>Drug use</topic><topic>Epidemiology</topic><topic>Health services</topic><topic>Hepatitis</topic><topic>Hepatitis C</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Indicators</topic><topic>Infections</topic><topic>Injection</topic><topic>Men</topic><topic>Narcotics</topic><topic>Opioids</topic><topic>Overdose</topic><topic>Prevention</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Trends</topic><topic>Viruses</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Evans, Mary E</creatorcontrib><creatorcontrib>Person Marissa</creatorcontrib><creatorcontrib>Reilley Brigg</creatorcontrib><creatorcontrib>Leston Jessica</creatorcontrib><creatorcontrib>Haverkate, Richard</creatorcontrib><creatorcontrib>McCollum, Jeffrey T</creatorcontrib><creatorcontrib>Apostolou Andria</creatorcontrib><creatorcontrib>Bohm, Michele K</creatorcontrib><creatorcontrib>Van Handel Michelle</creatorcontrib><creatorcontrib>Bixler Danae</creatorcontrib><creatorcontrib>Mitsch, Andrew J</creatorcontrib><creatorcontrib>Haberling, Dana L</creatorcontrib><creatorcontrib>Hatcher, Sarah M</creatorcontrib><creatorcontrib>Weiser, Thomas</creatorcontrib><creatorcontrib>Elmore, Kim</creatorcontrib><creatorcontrib>Teshale, Eyasu H</creatorcontrib><creatorcontrib>Weidle, Paul J</creatorcontrib><creatorcontrib>Peters, Philip J</creatorcontrib><creatorcontrib>Buchacz Kate</creatorcontrib><collection>PAIS Index</collection><collection>British Nursing Index</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>Public health reports (1974)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Evans, Mary E</au><au>Person Marissa</au><au>Reilley Brigg</au><au>Leston Jessica</au><au>Haverkate, Richard</au><au>McCollum, Jeffrey T</au><au>Apostolou Andria</au><au>Bohm, Michele K</au><au>Van Handel Michelle</au><au>Bixler Danae</au><au>Mitsch, Andrew J</au><au>Haberling, Dana L</au><au>Hatcher, Sarah M</au><au>Weiser, Thomas</au><au>Elmore, Kim</au><au>Teshale, Eyasu H</au><au>Weidle, Paul J</au><au>Peters, Philip J</au><au>Buchacz Kate</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014</atitle><jtitle>Public health reports (1974)</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>135</volume><issue>4</issue><spage>461</spage><epage>471</epage><pages>461-471</pages><issn>0033-3549</issn><eissn>1468-2877</eissn><abstract>Objectives Hepatitis C virus (HCV) and HIV transmission in the United States may increase as a result of increasing rates of opioid use disorder (OUD) and associated injection drug use (IDU). Epidemiologic trends among American Indian/Alaska Native (AI/AN) persons are not well known. Methods We analyzed 2010-2014 Indian Health Service data on health care encounters to assess regional and temporal trends in IDU indicators among adults aged ≥18 years. IDU indicators included acute or chronic HCV infection (only among adults aged 18-35 years), arm cellulitis and abscess, OUD, and opioid-related overdose. We calculated rates per 10 000 AI/AN adults for each IDU indicator overall and stratified by sex, age group, and region and evaluated rate ratios and trends by using Poisson regression analysis. Results Rates of HCV infection among adults aged 18-35 increased 9.4% per year, and rates of OUD among all adults increased 13.3% per year from 2010 to 2014. The rate of HCV infection among young women was approximately 1.3 times that among young men. Rates of opioid-related overdose among adults aged &lt;50 years were approximately 1.4 times the rates among adults aged ≥50 years. Among young adults with HCV infection, 25.6% had concurrent OUD. Among all adults with arm cellulitis and abscess, 5.6% had concurrent OUD. Conclusions Rates of HCV infection and OUD increased significantly in the AI/AN population. Strengthened public health efforts could ensure that AI/AN communities can address increasing needs for culturally appropriate interventions, including comprehensive syringe services programs, medication-assisted treatment, and opioid-related overdose prevention and can meet the growing need for treatment of HCV infection.</abstract><cop>Cary</cop><pub>SAGE PUBLICATIONS, INC</pub><doi>10.1177/0033354920937284</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3549
ispartof Public health reports (1974), 2020-07, Vol.135 (4), p.461-471
issn 0033-3549
1468-2877
language eng
recordid cdi_proquest_journals_2429086434
source JSTOR Archival Journals and Primary Sources Collection【Remote access available】; PAIS Index; Sage Journals Online; PubMed Central
subjects Abscesses
Adults
Cellulitis
Chronic infection
Disease transmission
Drug addiction
Drug use
Epidemiology
Health services
Hepatitis
Hepatitis C
HIV
Human immunodeficiency virus
Indicators
Infections
Injection
Men
Narcotics
Opioids
Overdose
Prevention
Public health
Regression analysis
Sexually transmitted diseases
STD
Trends
Viruses
Young adults
title Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A07%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Indicators%20of%20Injection%20Drug%20Use,%20Indian%20Health%20Service,%202010-2014&rft.jtitle=Public%20health%20reports%20(1974)&rft.au=Evans,%20Mary%20E&rft.date=2020-07-01&rft.volume=135&rft.issue=4&rft.spage=461&rft.epage=471&rft.pages=461-471&rft.issn=0033-3549&rft.eissn=1468-2877&rft_id=info:doi/10.1177/0033354920937284&rft_dat=%3Cproquest%3E2429086434%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1174-f2032ee6a4cc85f829adf1e9756259ba1929d061606c2309fc0602708adfff003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2429086434&rft_id=info:pmid/&rfr_iscdi=true